Jingjing Kang
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Oncology
- Immunology
- Topics
- Lung Cancer Diagnosis and Treatment (13 papers)Lung Cancer Treatments and Mutations (10 papers)Extracellular vesicles in disease (9 papers)
- Cited by
- Cancer ResearchPharmacologyGenetics
- Journals
- Journal of the American Chemical SocietyJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesBelarus
In The Last Decade
Jingjing Kang
56 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 472
- Pulmonary and Respiratory Medicine 285
- Cancer Research 171
- Oncology 165
- Immunology 164
Countries citing papers authored by Jingjing Kang
This map shows the geographic impact of Jingjing Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Kang more than expected).
Fields of papers citing papers by Jingjing Kang
This network shows the impact of papers produced by Jingjing Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Kang. The network helps show where Jingjing Kang may publish in the future.
Co-authorship network of co-authors of Jingjing Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Kang. A scholar is included among the top collaborators of Jingjing Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Kang. Jingjing Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 13 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 35 | |
| 12 | 13 | |
| 13 | 23 | |
| 14 | 32 | |
| 15 | 6 | |
| 16 | 28 | |
| 17 | 17 | |
| 18 | 21 | |
| 19 | 10 | |
| 20 | 87 |
About Jingjing Kang
Jingjing Kang is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Immunology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Extracellular vesicles in disease (9 papers). The work is most often cited by research in Cancer Research (171 citations), Pharmacology (88 citations) and Genetics (103 citations). Jingjing Kang has collaborated with scholars based in China, United States and Belarus. Frequent co-authors include Wenrong Xu, Yongmin Yan, Xu Zhang, Fei Mao, Hui Qian, Yunbing Wu, Xudong Tang, Bin Zhang, Zhouguang Hui and Xin Sun. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.